|
⚲
|
| Keyboard |
| Kalkofen Donald A
✚
|
|
|---|---|
| CIK # | 0001771066 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001771066] | |
| 4 | [0001771066] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Kalkofen Donald A | |
| Genvor Inc | |
| Protagonist Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2022-02-15 | Grant | 7,500 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2022-02-15 | Grant | 45,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2021-02-26 | Grant | 55,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2021-02-26 | Grant | 7,500 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2020-02-28 | Grant | 55,000 | $0.00 | |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2019-12-03 | Buy | 562 | $5.09 | 2,861 |
|
Protagonist Therapeutics Inc PTGX
Common Stock
|
2019-12-03 | Buy | 613 | $5.10 | 3,126 |
|
Protagonist Therapeutics Inc PTGX
Stock Option (right to buy) · derivative
|
2019-05-31 | Grant | 100,000 | $0.00 |